• News

"New Drug May Revolutionize Treatment For Skin Disease Eczema"

  • CBS
  • New York, NY
  • (October 17, 2016)

Treatments have not always been great for adults suffering from eczema. A new study in the New England Journal of Medicine shows that an experimental drug called Dupilumab may be the answer to severe, treatment-resistant eczema. “Dupilumab does it in a very specific fashion. It targets only the immune parts that is central to the disease and that’s why it lacks the side effects but yet, provides efficacy in the disease,” said Emma Guttman-Yassky, MD, PhD, a professor of dermatology at the Icahn School of Medicine at Mount Sinai. Learn more.